Caricamento...
Multiomics Prediction of Response Rates to Therapies to Inhibit Programmed Cell Death 1 and Programmed Cell Death 1 Ligand 1
IMPORTANCE: Therapies to inhibit programmed cell death 1 and its ligand (anti–PD-1/PD-L1) provide significant survival benefits in many cancers, but the efficacy of these treatments varies considerably across different cancer types. Identifying the underlying variables associated with this cancer ty...
Salvato in:
| Pubblicato in: | JAMA Oncol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Medical Association
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6707018/ https://ncbi.nlm.nih.gov/pubmed/31436822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.2311 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|